Cingulate Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Cingulate Inc
Access all reports
Cingulate Inc. is a biopharmaceutical company focused on developing treatments for central nervous system disorders. The company specializes in precision drug delivery technology to enhance the efficacy and control of medications. Its primary research targets attention-deficit/hyperactivity disorder (ADHD) and other cognitive and psychiatric conditions. Cingulate leverages its proprietary Precision Timed Release (PTR) platform to develop extended-release formulations for improved patient outcomes. The company is headquartered in Kansas City, Kansas, and its shares are listed on the NASDAQ.
Latest articles
)
Moncler: From the Mountains to the Runway
The story of Moncler, all the way from its beginnings in the Alps to its journey to some of the most prestigious runways in the world.
16 Apr 2025
)
eToro: Innovation, Growth, and IPO Plans
eToro was founded in 2007 and has grown into a global trading platform with over 40 million users and an extensive offering across several asset classes.
10 Apr 2025
)
Yum! Brands: The Company Behind Pizza Hut, KFC, and Taco Bell
Yum! Brands started at PepsiCo in the 1970s and is home to some of the most well-known brands in the world, such as Pizza Hut, KFC, and Taco Bell.
9 Apr 2025
Ticker symbol
CING
Country
🇺🇸 United States